The degree of collagen degradation, a process called collagen turnover, evident in a person’s blood at the time idiopathic pulmonary…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
A subset of fibroblasts that produce a protein called meflin in lung tissues taken from people with idiopathic pulmonary…
Changes in gene activity and immune cell populations in the lungs of people with chronic lung diseases, such as…
Enrollment has resumed, under a revised trial protocol, in the Phase 2b study GALACTIC-1, which is evaluating Galecto’s investigational inhaled…
A computer analysis identified a tiny RNA molecule, or microRNA, as a potential therapeutic target to halt the progression of…
A radioactive molecule that can be seen on positron emission tomography (PET) scans may offer a non-invasive way to identify…
The U.S. Food and Drug Administration (FDA) has accepted United Therapeutics’ application for…
Scientists found that mesenchymal stromal cells (MSCs) — cells that have similar properties to stem cells — individually…
Scientists have found a small molecule, called ISRIB, that was able to reduce fibrosis (scarring) and other disease-related…
Veracyte has presented new data demonstrating the diagnostic performance and utility of its…